This blog is related to the various litigations related to patents w.r.t pharma industry.
Tuesday, August 11, 2009
Teva Announces Approval and Launch of Oxaliplatin Injection
Aug 11, 2009 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) today announced U.S. Food and Drug Administration (FDA) approval and launch of Oxaliplatin Injection.
No comments:
Post a Comment